Core Viewpoint - DuPont has signed a final agreement to sell its aramid business, including the Kevlar and Nomex brands, to Arclin for approximately $1.8 billion, with the transaction expected to be completed in Q1 2026 [1] Group 1: Transaction Details - The sale will provide DuPont with about $1.2 billion in cash and $300 million in receivables, along with a non-controlling equity interest in Arclin valued at $325 million, expected to represent approximately 17.5% ownership upon completion [1] - DuPont's aramid business, which includes Kevlar and Nomex, has a projected net sales of $1.3 billion for 2024 and employs around 1,900 people across five production sites [1] Group 2: Strategic Implications - The CEO of DuPont, Lori Koch, stated that this sale is a significant step in optimizing the company's business portfolio, enhancing strategic focus, growth potential, and profit margins [1] - Arclin specializes in polymer technology, engineering products, and specialty materials, with operations in the United States, Canada, and the United Kingdom, serving a global market [1]